AVAILABLE MEDICINE FOR Darifenacin
There are no products to list.
Introduction to Darifenacin
Darifenacin is an antimuscarinic agent primarily used to treat overactive bladder (OAB), a condition characterized by urgency, frequency, and incontinence. By selectively inhibiting the M3 muscarinic receptor in the bladder, Darifenacin reduces involuntary bladder contractions, thereby improving bladder control and reducing urinary urgency.
How Darifenacin works
The mechanism of action involves blocking acetylcholine from binding to its receptors, which helps relax the detrusor muscle of the bladder. This action leads to increased bladder capacity and decreased episodes of urge incontinence, significantly enhancing the quality of life for individuals affected by OAB.
Uses of Darifenacin
Darifenacin is available in extended-release formulations, allowing for once-daily dosing. This convenient administration enhances patient adherence to treatment regimens.
Side effects of Darifenacin
Common side effects include dry mouth, constipation, and blurred vision, which are typical of anticholinergic medications. Serious side effects may include urinary retention and increased heart rate, necessitating careful monitoring.
The FDA approved Darifenacin in 2004 for the management of OAB, acknowledging its efficacy and safety profile. As a targeted treatment option, it offers significant benefits for patients seeking relief from the bothersome symptoms associated with overactive bladder.
